Literature DB >> 31067122

Recent HIV Risk Behavior and Partnership Type Predict HIV Pre-Exposure Prophylaxis Adherence in Men Who Have Sex with Men.

Jill Blumenthal1, David J Moore1, Sonia Jain1, Xiaoying Sun1, Eric Ellorin1, Katya Corado2, Martin Hoenigl1, Michael Dube3, Richard Haubrich4, Sheldon R Morris1.   

Abstract

Men who have sex with men (MSM) reporting higher HIV risk behavior over time are often more adherent to pre-exposure prophylaxis (PrEP), but it is unclear if recent risk behavior and partnership type affect long-term PrEP adherence. HIV-negative MSM and transgender women completing the 48-week randomized study TAPIR (Daily Text Messages to Support Adherence to PrEP in At-Risk for HIV Individuals) were included. At baseline and weeks 24 and 48, a modified Calculated Risk (mCalcR) Score estimated the likelihood of HIV seroconversion over 1 year based on reported condomless anal sex acts in the last month and current sexually transmitted infection. mCalcR scores were categorized as low, moderate, and high/very high risk. Partnership type was classified as no partner/single HIV-negative partner (no/single-), single HIV-positive partner (single+), or multiple partners of any serostatus (multi) in the past 3 months. PrEP adherence was measured by intracellular tenofovir-diphosphate (TFV-DP) levels. Among 313 individuals, there was no difference in mCalcR category from baseline to week 48. There was a significant change in partnership type, with no/single partnerships increasing from 0.5% to 9%. Participants with moderate and high/very risk had higher TFV-DP levels than the low-risk group. No/single participants had lower TFV-DP levels than those reporting single+ or multi. Although there was a shift toward lower-risk partnerships, HIV risk category remained stable over time. Individuals with riskier behaviors and partnerships had higher PrEP drug levels, suggesting continued motivation for and adherence to PrEP.

Entities:  

Keywords:  HIV prevention; HIV risk; medication adherence; men who have sex with men (MSM); partnerships; pre-exposure prophylaxis (PrEP)

Mesh:

Substances:

Year:  2019        PMID: 31067122      PMCID: PMC6531901          DOI: 10.1089/apc.2018.0289

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  24 in total

1.  Randomized Controlled Trial of an Internet Application to Reduce HIV Transmission Behavior Among HIV Infected Men Who have Sex with Men.

Authors:  Joel Milam; Sheldon Morris; Sonia Jain; Xiaoying Sun; Michael P Dubé; Eric S Daar; Gustavo Jimenez; Richard Haubrich
Journal:  AIDS Behav       Date:  2016-06

2.  Randomized Controlled Trial of Daily Text Messages to Support Adherence to Preexposure Prophylaxis in Individuals at Risk for Human Immunodeficiency Virus: The TAPIR Study.

Authors:  David J Moore; Sonia Jain; Michael P Dubé; Eric S Daar; Xiaoying Sun; Jason Young; Katya Corado; Eric Ellorin; Joel Milam; Deborah Collins; Jill Blumenthal; Brookie M Best; Peter Anderson; Richard Haubrich; Sheldon R Morris
Journal:  Clin Infect Dis       Date:  2018-05-02       Impact factor: 9.079

3.  Patterns and correlates of PrEP drug detection among MSM and transgender women in the Global iPrEx Study.

Authors:  Albert Liu; David V Glidden; Peter L Anderson; K Rivet Amico; Vanessa McMahan; Megha Mehrotra; Javier R Lama; John MacRae; Juan Carlos Hinojosa; Orlando Montoya; Valdilea G Veloso; Mauro Schechter; Esper G Kallas; Suwat Chariyalerstak; Linda-Gail Bekker; Kenneth Mayer; Susan Buchbinder; Robert Grant
Journal:  J Acquir Immune Defic Syndr       Date:  2014-12-15       Impact factor: 3.731

4.  Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.

Authors:  Michael C Thigpen; Poloko M Kebaabetswe; Lynn A Paxton; Dawn K Smith; Charles E Rose; Tebogo M Segolodi; Faith L Henderson; Sonal R Pathak; Fatma A Soud; Kata L Chillag; Rodreck Mutanhaurwa; Lovemore Ian Chirwa; Michael Kasonde; Daniel Abebe; Evans Buliva; Roman J Gvetadze; Sandra Johnson; Thom Sukalac; Vasavi T Thomas; Clyde Hart; Jeffrey A Johnson; C Kevin Malotte; Craig W Hendrix; John T Brooks
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

5.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Authors:  Jared M Baeten; Deborah Donnell; Patrick Ndase; Nelly R Mugo; James D Campbell; Jonathan Wangisi; Jordan W Tappero; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; Elioda Tumwesigye; Edwin Were; Kenneth H Fife; James Kiarie; Carey Farquhar; Grace John-Stewart; Aloysious Kakia; Josephine Odoyo; Akasiima Mucunguzi; Edith Nakku-Joloba; Rogers Twesigye; Kenneth Ngure; Cosmas Apaka; Harrison Tamooh; Fridah Gabona; Andrew Mujugira; Dana Panteleeff; Katherine K Thomas; Lara Kidoguchi; Meighan Krows; Jennifer Revall; Susan Morrison; Harald Haugen; Mira Emmanuel-Ogier; Lisa Ondrejcek; Robert W Coombs; Lisa Frenkel; Craig Hendrix; Namandjé N Bumpus; David Bangsberg; Jessica E Haberer; Wendy S Stevens; Jairam R Lingappa; Connie Celum
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

6.  Development of a clinical screening index predictive of incident HIV infection among men who have sex with men in the United States.

Authors:  Dawn K Smith; Sherri L Pals; Jeffrey H Herbst; Sanjyot Shinde; James W Carey
Journal:  J Acquir Immune Defic Syndr       Date:  2012-08-01       Impact factor: 3.731

7.  Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services.

Authors:  Albert Y Liu; Stephanie E Cohen; Eric Vittinghoff; Peter L Anderson; Susanne Doblecki-Lewis; Oliver Bacon; Wairimu Chege; Brian S Postle; Tim Matheson; K Rivet Amico; Teri Liegler; M Keith Rawlings; Nikole Trainor; Robert Wilder Blue; Yannine Estrada; Megan E Coleman; Gabriel Cardenas; Daniel J Feaster; Robert Grant; Susan S Philip; Richard Elion; Susan Buchbinder; Michael A Kolber
Journal:  JAMA Intern Med       Date:  2016-01       Impact factor: 21.873

8.  HIV moments and pre-exposure prophylaxis.

Authors:  Robert M Grant; David V Glidden
Journal:  Lancet       Date:  2016-04-07       Impact factor: 79.321

9.  Adherence to preexposure prophylaxis: current, emerging, and anticipated bases of evidence.

Authors:  K Rivet Amico; Michael J Stirratt
Journal:  Clin Infect Dis       Date:  2014-07       Impact factor: 9.079

10.  Couple-Level Dynamics and Multilevel Challenges Among Black Men Who Have Sex with Men: A Framework of Dyadic HIV Care.

Authors:  Judy Y Tan; Chadwick K Campbell; Amy A Conroy; Alyssa P Tabrisky; Susan Kegeles; Shari L Dworkin
Journal:  AIDS Patient Care STDS       Date:  2018-10-19       Impact factor: 5.078

View more
  1 in total

Review 1.  The Potential of Telecommunication Technology to Address Racial/Ethnic Disparities in HIV PrEP Awareness, Uptake, Adherence, and Persistence in Care: A Review.

Authors:  Kimberly N Evans; Rashida Hassan; Ashley Townes; Kate Buchacz; Dawn K Smith
Journal:  AIDS Behav       Date:  2022-05-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.